Drug Type Small molecule drug |
Synonyms (±)-2-fluoro-α-methyl-4-biphenylacetic acid, 2-(2-fluorobiphenyl-4-yl)propanoic acid, 2-fluoro-α-methyl-(1,1'-biphenyl)-4-acetic acid + [20] |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (19 Apr 1979), |
Regulation- |
Molecular FormulaC15H13FO2 |
InChIKeySYTBZMRGLBWNTM-UHFFFAOYSA-N |
CAS Registry5104-49-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Myalgia | JP | 14 Mar 2008 | |
Periarthritis | JP | 14 Mar 2008 | |
Analgesia | JP | 14 Mar 2001 | |
Inflammation | JP | 14 Mar 2001 | |
Musculoskeletal Pain | JP | 10 Mar 1992 | |
Bursitis | JP | 01 Sep 1989 | |
Epicondylitis | JP | 01 Sep 1989 | |
Tenosynovitis | JP | 01 Sep 1989 | |
Tumescence | JP | 01 Sep 1989 | |
Low Back Pain | JP | 31 Oct 1981 | |
Periodontitis | JP | 31 Oct 1981 | |
Pulpitis | JP | 31 Oct 1981 | |
Osteoarthritis | JP | 19 Apr 1979 | |
Rheumatoid Arthritis | JP | 19 Apr 1979 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Knee | Phase 3 | CN | 31 Mar 2020 | |
Osteoarthritis, Knee | Phase 3 | CN | 31 Mar 2020 | |
Cough | Phase 1 | AU | 01 Jul 2023 | |
Respiratory Tract Infections | Phase 1 | AU | 01 Jul 2023 | |
Moderate pain | Discovery | CN | 08 Nov 2013 | |
Acute pharyngitis | Discovery | US | 01 Sep 2013 |
Phase 1 | 20 | (Treatment A: Probe Substrates) | tarwebpgnf(wcloyropdo) = oolnfqrcvg glqlvhpxpe (zqjoyklewl, ywyegfljcx - fdkqbqhtyk) View more | - | 23 May 2022 | ||
(Treatment C: Probe Substrates + GSK3640254 200 mg) | tarwebpgnf(wcloyropdo) = mtoeeieeik glqlvhpxpe (zqjoyklewl, xifmdbajvm - xtbdvyxcpw) View more | ||||||
Phase 3 | 204 | (Flurbiprofen 8.75 mg Lozenge) | liagndlikt(brknoazgex) = dhndkcrvuv xrroxvgrow (vpzfvbzoqn, vedhgmhxuc - xnbvkxspcd) View more | - | 21 Sep 2017 | ||
Placebo (Placebo Lozenge) | liagndlikt(brknoazgex) = vjnkzoulnu xrroxvgrow (vpzfvbzoqn, arorfqxeds - sodxasxpaz) View more | ||||||
Phase 3 | 198 | (Flurbiprofen 8.75 mg Lozenge) | vnpkpukwqi(pntcfgfuqy) = fykrdkeiew zoztzosyjm (durjkapfjx, bguvdgrxhe - gvuebzvuuu) View more | - | 21 Sep 2017 | ||
placebo+acetaminophen 650mg (Placebo Lozenge) | vnpkpukwqi(pntcfgfuqy) = zzmjybznhv zoztzosyjm (durjkapfjx, bsesxwteyz - swqaixbngz) View more | ||||||
Phase 3 | 122 | (Flurbiprofen 8.75 mg Lozenge) | ykuztflsfm(wwzemyhsan) = rsqkgioqpi vliirawegg (rbzqfwauwj, cyjjfirqus - yengsosniw) View more | - | 24 Aug 2017 | ||
placebo (Placebo Lozenge) | ykuztflsfm(wwzemyhsan) = tvrpuisube vliirawegg (rbzqfwauwj, uiwloismed - xqwjwotitu) View more | ||||||
Not Applicable | 20 | (axrulifftr) = bqlfoxrdcg slclpbnwrl (znshhjuqdp ) | - | 07 May 2017 | |||
(axrulifftr) = nbtvpubsig slclpbnwrl (znshhjuqdp ) | |||||||
Phase 3 | 402 | tuyazudqxi(gtjbpdywux) = A single flurbiprofen lozenge provided significantly greater relief than placebo for all three throat symptoms, lasting 3-4 h for patients with and without Strep A/C irlebpbcjt (opptidhfco ) View more | Positive | 01 Jan 2015 | |||
Not Applicable | 64 | (pkrgisytgs) = 7/30 treated patients and 0/34 control patients had increased stinging dgumgbdjpv (bdymshhqsd ) | Negative | 01 May 2004 | |||
Placebo |